Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-003993
Filing Date
2022-04-11
Accepted
2022-04-11 16:30:41
Documents
1
Period of Report
2022-04-07

Document Format Files

Seq Description Document Type Size
1 form4-04112022_040417.html 4  
1 form4-04112022_040417.xml 4 6493
  Complete submission text file 0001415889-22-003993.txt   7883
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Moat Ross (Reporting) CIK: 0001857177 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 22819976